Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)
Rebecca Hein(Technical University of Munich), Nazneen Rahman(Institute of Cancer Research), Christina A. Clarke(Menlo School), Michael J. Kerin(Ollscoil na Gaillimhe – University of Galway), Thérèse Truong(Université Paris-Sud), Annegien Broeks, Kenneth Muir(Manchester Academic Health Science Centre), F. Ménégaux(Université Paris-Sud), Pascal Guénel(Inserm), Roger L. Milne(The University of Melbourne), Miroslaw K. Kapuscinski(The University of Melbourne), Matthias W. Beckmann(Universitätsklinikum Erlangen), Arif B. Ekici(University Medical Center Groningen), H. Bas Bueno-de-Mesquit(National Institute for Public Health and the Environment), Melanie Maranian(University of Cambridge), Daniel J. Park(The University of Melbourne), Elinor J. Sawyer(King's College London), Olivia Fletcher(Breast Cancer Care), Argyrios Ziogas(University of Copenhagen), Stig E. Bojesen(University of Copenhagen), M. Pilar Zamora(Universidad Autónoma de Madrid), Hermann Brenner(Universidad de Granada), Børge G. Nordestgaard(Gentofte Hospital), Puttisak Puttawibul(Prince of Songkla University), Alexander Hein, Andreas Schneeweiß(German Cancer Research Center), Melissa C. Southey(The University of Melbourne), Ian Tomlinson(Centre for Human Genetics), Emilie Cordina-Duverger(Université Paris-Sud), Peter A. Fasching(University of California, Los Angeles), Artitaya Lophatananon(University of Warwick), Hoda Anton-Culver(University of California, Irvine), Henrik Flyger(University of Copenhagen), Jose Ignacio Arias Perez(Hospital Monte Naranco), Volker Arndt(German Cancer Research Center), Javier Benítez(Spanish National Cancer Research Centre), Barbara Burwinkel(German Cancer Research Center), Heiko Müller(Mario Negri Institute for Pharmacological Research), Christa Stegmaier(Karolinska University Hospital), Frans B.L. Hogervorst(The Netherlands Cancer Institute), John L. Hopper(The University of Melbourne), Leslie Bernstein(City of Hope), Suthee Rattanamongkongul(Srinakharinwirot University), Nichola Johnson(Institute of Cancer Research), Christof Sohn(Heidelberg University), Julian Peto(London School of Hygiene & Tropical Medicine), Nicola Miller(Heidelberg University), Isabel dos‐Santos‐Silva(London School of Hygiene & Tropical Medicine), Frederick Marmee(Heidelberg University), Marjanka K. Schmidt(University of Cambridge)
Cited by 54
Related Papers
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k